Sponsor Pipeline

John Mascarenhas Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
0
Recruiting
1
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-07-29 NCT07734077 Revumenib in Patients With Myelofibrosis Phase 1/2 Not Yet Recruiting
Active Trials by Phase
Phase 2
2
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07447817 Selinexor and Pacritinib in JAK Inhibitor-naïve MF Patients With Cytopenias Myelofibrosis Not Yet Recruiting
NCT05467800 Study of Canakinumab in Patients With Myelofibrosis Primary Myelofibrosis Active, Not Recruiting
Phase 1/2
NCT07734077 Revumenib in Patients With Myelofibrosis Myelofibrosis Not Yet Recruiting
Disease Areas
Myelofibrosis (3)
Get alerts when John Mascarenhas's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free